EWOLUTION of Watchman Left Atrial Appendage Closure to Patients With Contraindication to Oral Anticoagulation

Affiliations

Editorial

Mohit K Turagam et al. Circ Arrhythm Electrophysiol. 2019 Apr.

. 2019 Apr;12(4):e007257.

doi: 10.1161/CIRCEP.119.007257.

¹ Helmsley Electrophysiology Center, Department of Cardiology, Icahn School of Medicine at Mount Sinai, NY.

No abstract available

Keywords: Editorials; atrial fibrillation; clopidogrel; contraindication; thromboembolism; warfarin.

Comment on

Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology: Final 2-Year Outcome Data of the EWOLUTION Trial Focusing on History of Stroke and Hemorrhage.
Boersma LV, Ince H, Kische S, Pokushalov E, Schmitz T, Schmidt B, Gori T, Meincke F, Protopopov AV, Betts T, Mazzone P, Foley D, Grygier M, Sievert H, De Potter T, Vireca E, Stein K, Bergmann MW; following investigators and institutions participated in the EWOLUTION study. Boersma LV, et al. Circ Arrhythm Electrophysiol. 2019 Apr;12(4):e006841. doi: 10.1161/CIRCEP.118.006841. Circ Arrhythm Electrophysiol. 2019. PMID: 30939908